Why Wealthy Investors Are Betting Big on AI and HealthTech

Jan de Vries · 2026-10-12

You've probably noticed something shifting in the investment world. The smart money isn't just chasing tech anymore—it's pouring into two areas that are reshaping how we live: artificial intelligence and healthcare technology. And the numbers back it up. The UBS Global Family Office Report 2026 found that 65% of family offices were already invested in AI, and 33% had allocations to AI-enabled healthcare. That's not a niche trend. That's a full-blown pivot. So what's driving it? Let's break it down. ### Europe's Massive Investment Push The European Union isn't holding back. Its InvestAI initiative aims to mobilize €200 billion (about $216 billion) for artificial intelligence, including funding for major AI infrastructure. That's a staggering amount of capital. But it doesn't stop there. The European Commission and the European Investment Bank Group launched BioTechEU to mobilize €10 billion (around $10.8 billion) for biotech and life sciences in 2026 and 2027. Why does this matter to you? Because when governments and institutions commit this kind of money, they're not just writing checks—they're building ecosystems. And ecosystems create opportunities. ### AI Gigafactories and Infrastructure Infrastructure is where you see the clearest signal. In July 2026, the EU requested up to seven AI Gigafactories, backed by up to €10 billion in EU and national funding. The expectation? These will unlock at least €20 billion (roughly $21.6 billion) in additional private investment across the Union. Think of it like building the highways before the cars arrive. Without the infrastructure, you can't scale. With it, everything accelerates. ### Life Sciences: Europe's Hidden Giant Life sciences already contribute nearly €1.5 trillion (about $1.62 trillion) in value to the EU economy and support 29 million jobs. That's not a small sector—it's a powerhouse. And the EU is doubling down. The Commission's life sciences strategy includes measures to make multi-country clinical trials easier to fund and €300 million (around $324 million) to stimulate procurement of innovations like next-generation vaccines and affordable cancer solutions. As investment moves into high-growth sectors, investors can also explore private-market opportunities through firms like Top Business Ventures, which operates across venture capital, private equity, and real estate markets. ### The AI and HealthTech Growth Engine Europe has a massive life sciences industry with major research institutions, healthcare systems, and rapidly expanding AI infrastructure. That combination is magnetic for investors. By April 2026, 19 AI Factories had been deployed across European supercomputers, supported by 13 regional AI Factory antennas. EU and participating EuroHPC countries have committed more than €2.6 billion (about $2.8 billion) to the AI Factories and Antennas initiative. Then there's the healthcare side. The European Health Data Space is designed to make health data easier to access and reuse securely across the EU for research, innovation, and regulatory purposes. That creates potentially valuable infrastructure for medical research and AI development. Other EU projects include building specialist datasets. Cancer Image Europe is expected to provide access to 60 million cancer images by the end of 2026. The 1+ Million Genomes initiative aims to provide secure access to genomic and associated clinical data. > "The convergence of AI and healthcare isn't just a trend—it's a fundamental shift in how we approach medicine, research, and investment." Interestingly, the EU is also trying to move AI from research into clinical settings. In 2026, the European Commission made €9 million (around $9.7 million) available for two large-scale pilots of AI-powered medical imaging, covering technologies like X-rays, CT scans, MRI, PET, and ultrasound. For investors, the attraction is clear: HealthTech is moving beyond laboratory research into real-world clinical testing and EU-backed deployment programs. ### The Capital Rotation Is Real It's tough to track exactly what every high-net-worth individual is investing in. Much private investment isn't publicly disclosed. But the signals are everywhere. Family offices are rebalancing. Venture capital is flowing. And the EU's ambitious funding programs are acting as a catalyst. The bottom line? If you're not paying attention to AI and HealthTech, you might be missing the biggest investment story of the decade. The smart money is already there. So ask yourself: where do you want to be?